Fundz

Nuvig Therapeutics

Menlo Park, California, United States · Biotechnology, Health Care, research

Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.

Key facts

Headquarters
Menlo Park, California, United States
Employees
26
Industries
Biotechnology, Health Care, research
Status
Private
Website
nuvigtherapeutics.com
LinkedIn
Company page

Recent activity at Nuvig Therapeutics

Nuvig Therapeutics funding history

DateRoundAmount
Dec 2024Series B$161.0M

Leadership

  • David J. Woodhouse, Chief Executive Officer
  • Alan Glicklich, Chief Medical Officer
  • Stephanie Wang, Chief of Staff
  • Joseph Leung, Senior Director

Verified email and direct lines for Nuvig Therapeutics’s decision-makers are on Fundz. See plans

Nuvig Therapeutics in the news

Companies similar to Nuvig Therapeutics

About Nuvig Therapeutics: questions and answers

What does Nuvig Therapeutics do?

Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.

Where is Nuvig Therapeutics headquartered?

Nuvig Therapeutics is headquartered in Menlo Park, California, United States.

How many employees does Nuvig Therapeutics have?

Nuvig Therapeutics has about 26 employees.

Has Nuvig Therapeutics raised funding?

Yes. Fundz has recorded 1 funding event for Nuvig Therapeutics. The most recent, Series B of $161.0M, was in Dec 2024.

Who leads Nuvig Therapeutics?

David J. Woodhouse is a Chief Executive Officer at Nuvig Therapeutics.

What is the latest news on Nuvig Therapeutics?

On Sep 09, 2025, Nuvig Therapeutics Appoints David J. Woodhouse as Chief Executive Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Nuvig Therapeutics across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.